Stock ABOS ACUMEN PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Acumen Pharmaceuticals, Inc.

Equities

ABOS

US00509G2093

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-10 pm EDT 		5-day change 1st Jan Change
3.36 USD -5.88% Intraday chart for Acumen Pharmaceuticals, Inc. -3.72% -12.50%
May. 08 Acumen Pharmaceuticals Doses 1st Patient in Alzheimer's Disease Drug Study MT
May. 08 Acumen Pharmaceuticals, Inc. Announces First Patient Dosed in Altitude-Ad, A Phase 2 Clinical Trial of Sabirnetug in Early Alzheimer?S Disease CI

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
ACUMEN PHARMACEUTICALS, INC.
Other Biotechnology & Medical Research
-5.88%-3.72%-12.50%-41.36% - 202M
Neutral
Bullish
Neutral
  1. Stock Market
  2. Equities
  3. ABOS Stock
  4. Charts Acumen Pharmaceuticals, Inc.
  5. Relative Strength Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW